gw8510 and sb 415286

gw8510 has been researched along with sb 415286 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buckner, FS; Domostoj, MM; Gelb, MH; Gillespie, JR; Napuli, AJ; Ojo, KK; Riechers, AJ; Scheer, A; Van Voorhis, WC; Verlinde, CL; Wells, SJ; Wells, TN	1

Other Studies

1 other study(ies) available for gw8510 and sb 415286

Article	Year
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Animals; Base Sequence; DNA Primers; DNA, Protozoan; Genes, Protozoan; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Protein Kinase Inhibitors; Recombinant Proteins; RNA Interference; Species Specificity; Trypanosoma brucei brucei; Trypanosomiasis, African	2008

Article

Year

Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.

Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

Topics: Animals; Base Sequence; DNA Primers; DNA, Protozoan; Genes, Protozoan; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Protein Kinase Inhibitors; Recombinant Proteins; RNA Interference; Species Specificity; Trypanosoma brucei brucei; Trypanosomiasis, African

2008